
|Videos|December 14, 2015
NOAC Dosing for Obese Patients vs. Non-Obese Patients
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
Advertisement
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Why Stanford, Harvard, and Yale Are Betting on Psychedelics
2
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
3
Comprehensive Lancet Review Reaffirms Safety, Effectiveness of mRNA Vaccines
4
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
5










































































































